CAS: 2049868-46-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK963 (Racemate) REF: AN-AG01FW4OCAS: 2049868-46-2 | 98+% | To inquire | Tue 21 May 24 |
 | GSK963 REF: TM-T5054CAS: 2049868-46-2 | 98.68% | 35.00 €~543.00 € | Tue 28 May 24 |
 | GSK'963 REF: 3D-ZGD86846CAS: 2049868-46-2 | Min. 95% | To inquire | Mon 01 Jul 24 |
GSK963 (Racemate)
CAS:2049868-46-2
Formula:
C14H18N2O
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
230.3055
Ref: AN-AG01FW4O
| 1g | To inquire | |
| 100mg | 564.00 € | |
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
GSK963
CAS:2049868-46-2
GSK963 (Racemate), a structurally distinct, potent and selective inhibitor of RIP1 kinase(IC50=29 nM).
Formula:
C14H18N2O
Purity:
98.68%
Color and Shape:
Solid
Molecular weight:
230.31
Ref: TM-T5054
| 1mg | 35.00 € | |
| 2mg | 50.00 € | |
| 5mg | 78.00 € | |
| 10mg | 118.00 € | |
| 25mg | 231.00 € | |
| 50mg | 371.00 € | |
| 100mg | 543.00 € | |
| 1ml*10 (DMSO) | 85.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
GSK'963
CAS:2049868-46-2
GSK'963 is a peptide-based activator of the nicotinic acetylcholine receptor that binds to the α4β2 …
Formula:
C14H18N2O
Purity:
Min. 95%
Molecular weight:
230.31 g/mol
Ref: 3D-ZGD86846
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
